(-0.01%) 5 468.54 points
(0.10%) 39 152 points
(0.25%) 17 761 points
(0.09%) $80.90
(-5.04%) $2.62
(-0.80%) $2 312.10
(-0.11%) $28.84
(3.25%) $1 018.50
(0.34%) $0.936
(0.76%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products...
Stats | |
---|---|
Šios dienos apimtis | 3 886 |
Vidutinė apimtis | 14 579 |
Rinkos kapitalizacija | 21.93M |
EPS | $-0.0161 ( Q1 | 2024-05-09 ) |
Kita pelno data | ( $-0.0100 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-14.86 (Sector) 42.63 (Industry) 0 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-30 | Amron Arthur H | Buy | 3 000 | Common Stock |
2024-05-28 | Amron Arthur H | Buy | 2 000 | Common Stock |
2024-05-16 | Banks Robert R. Jr. | Buy | 50 000 | Common Stock |
2024-05-14 | Banks Robert R. Jr. | Buy | 10 406 | Stock Option (right to buy) |
2024-05-14 | Amron Arthur H | Buy | 7 323 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
19.09 |
Last 97 transactions |
Buy: 1 543 813 | Sell: 673 582 |
Nephros Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
TTEC | 0.961 |
TWKS | 0.959 |
SMSI | 0.958 |
UONEK | 0.956 |
XMTR | 0.952 |
CLEU | 0.951 |
HRZN | 0.951 |
UONE | 0.951 |
RETO | 0.946 |
EEIQ | 0.945 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
EBAY | -0.962 |
MNMD | -0.961 |
ROOT | -0.958 |
RNA | -0.958 |
IINN | -0.953 |
PUBM | -0.95 |
CRAI | -0.949 |
NTRA | -0.949 |
PPC | -0.947 |
LFMDP | -0.942 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Nephros Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $14.24M |
Bruto pelnas: | $8.19M (57.53 %) |
EPS: | $-0.150 |
FY | 2023 |
Pajamos: | $14.24M |
Bruto pelnas: | $8.19M (57.53 %) |
EPS: | $-0.150 |
FY | 2022 |
Pajamos: | $9.98M |
Bruto pelnas: | $4.73M (47.43 %) |
EPS: | $-0.710 |
FY | 2021 |
Pajamos: | $10.40M |
Bruto pelnas: | $5.74M (55.20 %) |
EPS: | $-0.385 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Nephros Inc
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.